COMMUNIQUÉS West-GlobeNewswire

Decisely Celebrates its Place on the 2024 Inc. 5000 List of Fastest-Growing Private Companies
14/08/2024
ALPHARETTA, GA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Decisely, a leading provider of health benefits and management solutions for business owners, is proud to announce its inclusion in the prestigious Inc. 5000 list for [...]
SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update
13/08/2024
DENVER, Aug. 13, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage medical device company developing proprietary solutions to reduce the [...]
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024
13/08/2024
Guardion Also Provides an Update to Stockholders of Significant Recent Developments HOUSTON, TEXAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a [...]
Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
13/08/2024
• AMPLIFY-7P Phase 1 preliminary disease-free (“DFS”) survival demonstrates strong correlation between T cell response and reduced risk of progression or death • AMPLIFY-7P Phase 1 data presented at ASCO demonstrated [...]
Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
13/08/2024
- Sutro will present updated data from the ongoing Phase 1b study of luvelta in combination with bevacizumab in a poster presentation at ESMO 2024; expansion study is ongoing with data expected in the first half of 2025 [...]
BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results
13/08/2024
SUNNYVALE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported [...]
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
13/08/2024
SAN DIEGO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies [...]
Bavarian Nordic Receives Order from HERA and Announces Significant Donation of Vaccines in Response to the Mpox Outbreak in Africa
13/08/2024
HERA will procure 175,420 doses for immediate response to the concerning mpox outbreak in Africa, and furthermore, Bavarian Nordic will donate 40,000 doses to HERA, also to be distributed to the Africa CDC. COPENHAGEN, [...]
Panbela Provides Business Update and Reports Q2 2024 Financial Results
13/08/2024
MINNEAPOLIS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today [...]
SELLAS Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Update
13/08/2024
- Announced Independent Data Monitoring Committee’s (IDMC) Recommendation to Continue the Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Without Modifications: Interim Analysis Anticipated by Q4 2024 [...]
Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates
13/08/2024
– Patients dosed in Phase 1/2 INSPIRE DUCHENNE trial of SGT-003 for the treatment of Duchenne muscular dystrophy (Duchenne); Dosing was well tolerated in all patients with initial data expected Q4 2024 – – Solid plans [...]
UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq
13/08/2024
AI Technology to Assist Clinicians to Drive Better Outcomes in Brain Health TORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial [...]
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
13/08/2024
PDUFA goal date of November 4, 2024 for DFD-29 for the treatment of inflammatory lesions and erythema of rosacea in adults FDA accepted Biologics License Application resubmission for cosibelimab to treat metastatic or [...]
Glass House Brands Reports Record Setting Second Quarter 2024 Financial Results
13/08/2024
- Greenhouse 5 completed its first full quarter of production and sales in Q2, outperforming expectations - Record quarterly highs included consolidated revenue and gross profit, wholesale biomass revenue and gross [...]
ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes
13/08/2024
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the closing of its offering of $316,250,000 aggregate principal amount of 2.25% [...]
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
13/08/2024
– Initiated patient dosing in ESK-001 Phase 3 ONWARD clinical program in moderate-to-severe plaque psoriasis – – Initiated Phase 1 clinical trial for A-005 in healthy participants – – Completed IPO and private placement [...]
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights
13/08/2024
– Dose finding ongoing in Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including AML – – Commencement of $8 million grant award from CIRM for the clinical [...]
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
13/08/2024
DALLAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the second quarter ending June 30 [...]
Trinity Biotech to Announce Q2 2024 Financial Results
13/08/2024
Conference Call Scheduled for Wednesday, August 14, 2024 at 8:30 AM ET DUBLIN, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on [...]

Pages